Project Details
Description
Prospective, observational trial evaluating Xeomin (incobotulinumtoxin A) for cervical dystonia or blepharospasm in the United States
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/11 → 2/14/13 |
Funding
- MERZ PHARMACEUTICALS, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.